The veterinary pain management drugs market is anticipated to grow at a significant CAGR of 3.8% during the forecast period (2022-2028). Pain and inflammation linked with illnesses in animals are controlled with veterinary pain management drugs. These medications are used in the treatment of animal ailments and are an important component of veterinary therapy. The major players in the industry are working on a variety of targeted pain medications. Some of the factors propelling the growth of the global veterinary pain management drugs market includes the high prevalence of inflammatory and painful diseases amongst all animals. The frequency of osteoarthritis in dogs was estimated to be 20% globally, according to an article published by Veterinary Practice News in June 2020. Similarly, around 6 million dogs are diagnosed with cancer each year, according to an article released by the American Animal Health Association in April 2021. According to the Veterinary Cancer Society, one out of every four dogs will have cancer at some point, and around half of all dogs over the age of ten will develop cancer. Additionally, the rising government initiatives towards animal health concerns are driving the growth of the market. For instance, in October 2020, FECAVA launched a campaign titled “FECAVA Basic Practices in Anesthesia and Analgesia” which will include important lectures around Europe in the upcoming years and a series of six ready-to-use, printable posters/infographics regarding anaesthesia and pain management in animals.
The global veterinary pain management drugs market is segmented based on type, animal type, and application. Based on type, the market is sub-segmented into NSAIDs, agonists, anaesthetics, opioids, DMOAD, and others. Among these types, the opioids segment holds the major share in the market due to the added benefits of drugs in pain management. The opioids are mostly preferred by veterinary doctors for the treatment of inflammatory pain in animals. Based on animal type, the market is sub-segmented into companion animals and livestock animals. Based on application, the market is sub-segmented into osteoarthritis, musculoskeletal disorders, cancer, and others.
The market players are also contributing significantly to the market’s growth by adopting various strategies, including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in 2020, Cronus Pharma announced that it has got approval from the US Food & Drug Administration (FDA) for Carprofen Chewable Tablets (generic version of Rimadyl—Zoetis) for dogs. This nonsteroidal anti-inflammatory drug (NSAID) has been proven safe and effective in relieving pain and inflammation associated with osteoarthritis. Furthermore, it helps control postoperative pain associated with soft tissue and orthopaedic surgeries. Similarly, in January 2022, Elanco Animal Health announced that the company has received approval from the US FDA for Zorbium (buprenorphine transdermal solution) as it expands its pain management offerings while addressing an unmet need for veterinary practices.
(Get 15% Discount on Buying this Report)
Get Sample Copy of Veterinary Pain Management Drugs Market at: https://orionmarketreports.com/request-sample/?id=97381&submit=Request+Sample%0D%0A
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
- By Type
- By Animal Type
- By Application
- By Distribution Channel
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape– Ceva Sante Animale, Zoetis Inc., Vetoquinol SA, Boehringer Ingelheim International GmbH, Bayer AG, Norbrook Laboratories Ltd., and Merck & Co Inc., among others.
A full report Veterinary Pain Management Drugs Market of is available at: https://orionmarketreports.com/veterinary-pain-management-drugs-market/97381/
Global Veterinary Pain Management Drugs Market Report by Segment
By Type
- NSAIDs
- Agonists
- Anaesthetics
- Opioids
- DMOADs
- Others
By Animal Type
- Companion Animals
- Livestock Animals
By Application
- Osteoarthritis
- Musculoskeletal Disorders
- Cancer
- Others
By Distribution Channel
- Veterinary Hospitals
- Clinics
- Others
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
